fiveonefour | $17,000,000 | (Sep 5, 2025)
Sesh Products | $40,000,000 | (Sep 5, 2025)
Pointsville | Undisclosed Amount | (Sep 5, 2025)
Certified by Founder
Lodge
Psylo
start up
Australia
- Sydney, NSW
- 04/06/2024
- Seed
- $8,000,000
Psylo is a drug development company focused on next generation psychedelics; our goal is to make broadly accessible medicines as improved treatments to currently available SSRI medications, using psychedelic molecules as the starting point. We are building a pipeline of novel molecules with the ultimate goal of taking leading candidates through to clinical trials.
- Industry Biotechnology
- Website https://psylo.bio/
- LinkedIn https://www.linkedin.com/company/psylo/
Augment | $85,000,000 | (Sep 5, 2025)
Plural(US) | $7,000,000 | (Sep 5, 2025)
Hello Patient | $22,500,000 | (Sep 5, 2025)
Euclid Power | $20,000,000 | (Sep 5, 2025)
Lead | $70,000,000 | (Sep 5, 2025)
Pave Finance | $14,000,000 | (Sep 5, 2025)
throxy (yc x25) | $6,200,000 | (Sep 5, 2025)
Human Behavior (YC X25) | $5,000,000 | (Sep 5, 2025)
FlexifyMe | $2,400,000 | (Sep 5, 2025)